NCT07360639

Brief Summary

The goal of this Clinical trial is to Determine the effectiveness of a cream combining Gayo Arabica coffee bean extract and Aceh patchouli compared to urea cream for dry skin in Patients with dry skin, aged 18-65 years old who meet the inclusion criteria. The main question it aims to answer is: Can cream combination of Gayo Arabica coffee husk extract and Aceh patchouli be used on humans? is cream combination of Gayo Arabica coffee husk extract and Aceh patchouli clinically effective in improving dry skin Researchers will compare cream combination of Gayo Arabica coffee bean extract and Aceh patchouli to 10% urea cream see the better outcome. Participants will apply the cream corresponding to their group for twice a day for 6 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jun 2025

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2025

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 11, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 22, 2026

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

January 11, 2026

Last Update Submit

January 16, 2026

Conditions

Keywords

Coffeepatchoulixerosisantioxidantherbal

Outcome Measures

Primary Outcomes (2)

  • herbal cream effectiveness in treating dry skin

    this outcome was assessed the effectiveness of the cream by using overall dry skin score (ODSS) and the difference value of transepidermal water loss (TEWL). this assessment was carried out using physiological change such as scaling, itching, pain, erythema, and fissures. The water loss was assessed in the unit of grams per square meter per hour (g/m²/h)

    6 weeks

  • the safety assessment of herbal cream application on human skin

    the cream safety was assessed using international contact dermatitis research group (ICDRG) standard. this tool graded the physiological change based on the lesion that appeared.

    96 hours after cream application

Study Arms (3)

safety check subject

ACTIVE COMPARATOR

this subject receive cream combination of Gayo Arabica coffee husk extract and Aceh patchouli as patch test to test the safety of this cream combination. The result was documented at 48 hours, 72 hours, and 96 hours after patch application and assessed using International Contact Dermatitis Research Group standard

Drug: combination cream

experimental group

ACTIVE COMPARATOR

this group received cream combination of Gayo Arabica coffee husk extract and Aceh patchouli to be applied at the dry skin. The cream applied twice daily. Assessment was done at 6 weeks after cream application

Drug: combination cream

Control group

OTHER

this group received cream containing 10% urea to be applied at the dry skin. The cream applied twice daily. Assessment was done at 6 weeks after cream application

Drug: control cream

Interventions

cream containing gayo arabica coffee husk extract and aceh patchouli extract was made. The cream formulation method was taken from previous research

experimental groupsafety check subject

this intervention was application of cream containing 10% urea as the standard method in treatment of xerosis cutis

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18-65 years old
  • Diagnosed with xerosis cutis
  • not using any moisturizer for more than 2 weeks
  • dry skin at extremity

You may not qualify if:

  • no history of coffee, patchouli, urea, or cream composition allergy
  • secondary infection lession appeared
  • pregnant or breastfeeding woman
  • history of using another topical drug

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

dr. Zainoel Abidin General Hospital

Banda Aceh, Nanggore Aceh Darussalam, 23126, Indonesia

Location

Related Publications (3)

  • Lestari W, Hasballah K, Listiawan MY, Sofia S. Metabolite Signature of Fresh and Long-term Stored Coffee Pulp and Husk. Makara J Sci [Internet]. 30 September 2022;26(3).

    BACKGROUND
  • Paradila ED, Prasetya F, Almeida M. Formulasi Sediaan Krim Body scrub dari Serbuk Kopi yang Dikombinasikan dengan Minyak Zaitun sebagai Pencerah dan Pelembab Kulit. Proceeding Mulawarman Pharm Conf [Internet]. 31 Mei 2022;15:48-52.

    BACKGROUND
  • Lestari W, Dewi Ismida F, Hajar S, Clarissa Namiko R. The Effect of Combination Cream of Patchouli Extract and Arabica Gayo Coffee Peel Extract on Aging Skin. Berk Ilmu Kesehat Kulit dan Kelamin [Internet]. 31 Juli 2024;36(2):113-22.

    BACKGROUND

MeSH Terms

Interventions

Lidocaine, Prilocaine Drug Combination

Intervention Hierarchy (Ancestors)

LidocaineAcetanilidesAnilidesAmidesOrganic ChemicalsPrilocaineAniline CompoundsAminesDrug CombinationsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 11, 2026

First Posted

January 22, 2026

Study Start

June 1, 2025

Primary Completion

December 20, 2025

Study Completion

December 20, 2025

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

IPD will not (or might not) be shared due to ethical considerations, data ownership restrictions, and the need to protect participant confidentiality, as the data are sensitive and collected under informed consent that limits secondary use

Locations